Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. The aims of Pharmacovigilance programs are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.

Dexa Group is committed to continuously evaluating the benefit/risk profile of our products. In the event of any adverse drug events occur during the use of Dexa Group’s product(s), healthcare providers, patients, and consumers may directly report to us through our website contact us (click here).

All of the adverse event reports would be highly appreciated and provides valuable feedback for us. Thank you for your cooperation and participation in reporting the adverse event reports of Dexa Group’s product(s).

Corporate Pharmacovigilance

Dexa Group

Email :

Sun Mercury